Literature DB >> 2435808

Antigenic presentation of small molecules and peptides conjugated to a preformed iscom as carrier.

K Lövgren, J Lindmark, R Pipkorn, B Morein.   

Abstract

The aim of the present study was to elaborate a carrier system for haptens and synthetic peptides, making them immunogenic without addition of Freund's adjuvants. As carriers, preformed iscoms and micelles as well as BSA have been compared. The iscoms and micelles were prepared with envelope proteins of an influenza virus. As a model hapten, the small molecules of biotin were coupled to iscoms to determine the optimum epitope density for induction of an enhanced antibody response to the hapten. The most efficient carrier tested was the preformed iscom at an epitope density of ten biotin molecules per viral protein in the iscom. This carrier system exceeded the efficacy of both the preformed micelles and BSA, the latter with or without addition of Freund's adjuvant. A favourable epitope density could not be achieved when each of two different synthetic peptides was conjugated to iscoms. Epitope densities higher than one to three peptide molecules per protein lead to polymerization of either the peptide or the carrier. The coupling agent was glutardialdehyde.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435808     DOI: 10.1016/0022-1759(87)90447-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration.

Authors:  K Lövgren; H Kåberg; B Morein
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Inflammatory response and antigen localization following immunization with influenza virus ISCOMs.

Authors:  D L Watson; K Lövgren; N A Watson; C Fossum; B Morein; S Höglund
Journal:  Inflammation       Date:  1989-12       Impact factor: 4.092

3.  Immunogenicity of liposomes and iscoms containing the major outer membrane protein of Neisseria gonorrhoeae: influence of protein content and liposomal bilayer composition.

Authors:  G F Kersten; A M van de Put; T Teerlink; E C Beuvery; D J Crommelin
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

4.  Expression of recombinant proteins on the surface of the coagulase-negative bacterium Staphylococcus xylosus.

Authors:  M Hansson; S Ståhl; T N Nguyen; T Bächi; A Robert; H Binz; A Sjölander; M Uhlén
Journal:  J Bacteriol       Date:  1992-07       Impact factor: 3.490

Review 5.  Adjuvant effects of saponins on animal immune responses.

Authors:  Zahid Iqbal Rajput; Song-hua Hu; Chen-wen Xiao; Abdullah G Arijo
Journal:  J Zhejiang Univ Sci B       Date:  2007-03       Impact factor: 3.066

6.  The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses.

Authors:  K F Hu; M Elvander; M Merza; L Akerblom; A Brandenburg; B Morein
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

7.  The induction of cell-associated and secreted IL-1 by iscoms, matrix or micelles in murine splenic cells.

Authors:  M Villacres-Eriksson; M Bergström-Mollaoglu; H Kåberg; K Lövgren; B Morein
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

8.  Generation, characterization and cross-reactivities of monoclonal antibodies against the p24 core protein and the gp130 envelope glycoprotein of HIV-2ben.

Authors:  A C Faisst; A Otteken; S Nick; G Hunsmann
Journal:  Med Microbiol Immunol       Date:  1993-07       Impact factor: 3.402

9.  Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice.

Authors:  F G Araujo; B Morein
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses.

Authors:  M Ugozzoli; D T O'Hagan; G S Ott
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.